Tissue hypoxia in Crohn’s disease in children: markers and coping methods
https://doi.org/10.31146/1682-8658-ecg-185-1-106-110
Abstract
Objective: to identify markers of tissue hypoxia in Crohn’s disease in children: markers and methods for overcoming it.
Materials and methods: 27 children with Crohn’s disease (CD) aged from 1 year to 18 years were examined. Histological, histomorphometric and immunohistochemical analysis of biopsy samples of the colon mucosa.
Results: morphological markers of tissue hypoxia in CD were identified: the presence of predominantly immature fibroblasts, infiltration of the muscle plate by neutrophilic granulocytes, necrotizing vasculitis, the phenomenon of the grouping of inactive macrophages with each other with the formation of multinucleated cells, which are the precursors of multinucleated granules according to the Pigorov-Lanhans type
Conclusion: in identifying markers of tissue hypoxia, leading to a worsening prognosis of the course of CD and the development of complications, it is necessary to determine the tactics of accelerated “step-up” therapy using anticytokine drugs and use the method of hyperbaric oxygenation.
About the Authors
E. N. FedulovaRussian Federation
Elvira N. Fedulova, MD, DSc, Chief Researcher of the Department of Rheumatological and Other Systemic Diseases
N. Novgorod, pl. Minin Pozharsky, d10 / 1, 603155, Russia
O. V. Shumilova
Russian Federation
Olga V. Shumilova, Ph.D., junior researcher of the department of «Rheumatological and other systemic diseases»
N. Novgorod, pl. Minin Pozharsky, d10 / 1, 603155, Russia
N. Yu. Shirokova
Russian Federation
Natalya Yu. Shirokova, Ph.D., Researcher, Laboratory and Diagnostic Department, Morphological Research Group
N. Novgorod, pl. Minin Pozharsky, d10 / 1, 603155, Russia
References
1. Baranov A. A., Potapov A. S., Tsimbalova E. G. Moden technology for diagnosis and treatment of inflammatory bowel diseases in children. Bulletin of the RAMS. 2011. No. 6, pp.36–41.
2. Kornienko, E. A. Inflammatory bowel disease in children. Moscow. Prima Print, 2014, 208 p.
3. Vorobiev G. I., Khalif I. L. Inflammatory bowel disease. Moscow, Miklos, 2008, 424 p.
4. Satsangi J., Satsangi J., Silverberg M. S., Vermeire S., Colombel J. F. The Monreal classification of inflammatory bowel disease: controversies, consensus and implications. Gut, 2006, vol. 55, pp. 749–753.
5. Romberg-Camps M.J., Dagnelie P. C., Kester A. D., et al. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease. Am. J. Gastroenterol, 2009, vol. 104, pp. 371–383.
6. Adler G. Crohn’s disease and ulcerative colitis. G. Adler; per. with him. Moscow. GOETAR-Media, 2001. 527 p.
7. Gupta N., Cohen S. A., Bostrom A. G., et al. Risk factors for initial surgery in pediatric patiens with Crohn’s disease. Gastroenterology, 2006, vol. 130, pp. 1069–1077.
8. Fedulova E. N., Shumilova O. V., Shirokova N. Yu. Early morphological criteria for complicated crohn forms in children. Experimental and Clinical Gastroenterology. 2017;(10):15–19.
9. Kornienko E. A., Khavkin A. I., Fedulova E. N., et al. Draft recommendations of the russian society of pediatric gastroenterology, hepatology and nutrition on diagnosis and treatment of Crohn’s disease in children. Experimental and Clinical Gastroenterology. 2019;(11):100–134. (In Russ.) Doi:10.31146/1682–8658‑ecg‑171–11–100–134
Review
For citations:
Fedulova E.N., Shumilova O.V., Shirokova N.Yu. Tissue hypoxia in Crohn’s disease in children: markers and coping methods. Experimental and Clinical Gastroenterology. 2021;1(1):106-110. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-185-1-106-110